| Sign In to gain access to subscriptions and/or personal tools. |
A 26-Week Carcinogenicity Study of 2-Amino-3-Methylimidazo[4,5-f]Quinoline in rasH2 Mice
1 Laboratory of Veterinary Pathology, Tokyo University of Agriculture and Technology, 3-5-8 Saiwai-cho, Fuchu City, Tokyo, Japan Correspondence: Address correspondence to Miwa Okamura, Laboratory of Veterinary Pathology, Tokyo University of Agriculture and Technology, 3-5-8 Saiwai-cho, Fuchu City, Tokyo 183-8509, Japan; e-mail:mokamura{at}cc.tuat.ac.jp
To evaluate the carcinogenic susceptibility of rasH2 mice to 2-amino-3-methylimidazo[4,5- f ]quinoline (IQ), 7-week-old rasH2 mice and their wild-type littermates (non-Tg mice) of both the sexes were fed a diet containing 0 or 300 ppm IQ for 26 weeks. Microscopical examinations revealed that the proliferative lesions of the forestomach, including squamous cell hyperplasias, papillomas, and carcinomas, were frequently encountered in male and female rasH2 mice fed with IQ. In non-Tg mice, no significant differences in the incidence of forestomach lesions were observed between the 0 ppm and 300 ppm groups. Histopathological changes such as periportal hepatocellular hypertrophy and oval cell proliferation in the liver were more apparent in female rasH2 and non-Tg mice than in males, and the incidence of hepatocellular altered foci significantly increased in female rasH2 mice in the 300 ppm group as compared to that in the 0 ppm group. These results suggest that the carcinogenic potential of IQ can be detected in rasH2 mice by a 26-week, short-term carcinogenicity test.
Key Words: rasH2 mice • IQ • carcinogenicity • heterocyclic amine • forestomach • transgenic mice
The rasH2 mouse is a hemizygous transgenic mouse carrying 3 copies of the prototype human c-Ha-ras gene with its own promoter integrated into the genome in a tandem array (Saito et al., 1990; Suemizu et al., 2002). Based on previous studies, it is well recognized that rasH2 mice are very susceptible to genotoxic carcinogens; therefore, they are generally accepted as an alternative animal model and used in place of long-term carcinogenicity tests (Yamamoto et al., 1996; Usui et al., 2001; Morton et al., 2002). On the other hand, since rasH2 mice cannot always detect all types of carcinogens, it is necessary to validate the carcinogenic susceptibility of these mice to various chemicals for appropriate evaluation of carcinogenic substances. 2-Amino-3-methylimidazo[4,5- f ]quinoline (IQ) is one of the genotoxic and carcinogenic heterocyclic amines (HCAs) produced during the cooking of meat and fish (Ohgaki et al., 1984; Sugimura et al., 2004). It has been reported that long-term treatment with 300 ppm IQ induced tumors in the liver, lung, and forestomach of CDF1 mice (Ohgaki et al., 1984) and in the liver, small and large intestines, Zymbal gland, clitoral gland, and skin of F344 rats (Takayama et al., 1984). In addition, IQ has been demonstrated to possess carcinogenic potential in monkeys (Adamson et al., 1990). Although data with a direct relevance to the carcinogenicity of IQ to humans were unavailable, IQ is considered to be probably carcinogenic to humans (IARC, 1993). Recently, HCAs have been tested in several transgenic and knockout mice models, and it was expected that application of such models would provide useful information on HCAs-induced mutagenesis and car- cinogenesis and also on chemopreventive agents (Dashwood, 2003). However, these newly developed animal models were not always susceptible to IQ (Sorensen et al., 1996; Dashwood, 2003; Ogawa et al., 2005). In the present study, we performed a short-term carcinogenicity study of IQ in order to evaluate the carcinogenic susceptibility of rasH2 mice to this chemical compound.
Animals and Chemicals Male and female rasH2 mice and their wild-type litter-mates (non-Tg mice) were purchased from CLEA Japan Inc. (Tokyo, Japan). They were housed in plastic cages (each cage contained 5 animals) with absorbent paper chip bedding in an animal room maintained under standard conditions (room temperature, 22 ± 23C; relative humidity, 55% ± 5%; and light/dark cycle, 12 h). Food and water were made available ad libitum throughout the experimental period. The animals were acclimatized for 1 week prior to the beginning of experiments; at this time, the animals were 7 weeks of age. The experiment was performed in accordance with the guidelines for animal experimentation of the Faculty of Agriculture, Tokyo University of Agriculture and Technology. IQ was purchased from Nard Institute (Osaka, Japan). The presence of contaminants in IQ measured by elementary analysis, infrared and mass spectra and HPLC was less than 0.4%. The preparation of IQ-containing diet was carried out in accordance with a previous report (Ohgaki et al., 1984), and the diet was stored at 4°C in a refrigerator prior to use. We used CA-1 (CLEA Japan, Inc.) as the basal diet.
Experimental Design
Statistical Analysis
The data of survival rate, initial and final body weight, average food consumption, and mean actual intake of IQ are summarized in Table 1. One male rasH2 mouse and 4 female rasH2 mice fed with a diet containing 300 ppm IQ died during the experimental period. A male rasH2 mouse died in week 26, and the pathological examination revealed a subcutaneous hemangiosarcoma of the lower part of the abdomen, inflammation of the prostate, transitional cell hyperplasia of the bladder, and squamous cell papilloma of the forestomach. No obvious abnormalities were found in female rasH2 mice that died in week 16–23, and the cause of their death could not be determined. Body weight gain in all rasH2 and non-Tg mice in the 300 ppm group decreased as compared to the 0 ppm group from the early stage of the experiment; the final body weight of both mice in the 300 ppm group was significantly lower than those in the 0 ppm group. The food consumption of both rasH2 mice and non-Tg mice in the 300 ppm group slightly decreased when compared with those in the 0 ppm group. The mean actual intake of IQ of the rasH2 mice and non-Tg mice were 37.2 ± 4.3 mg/kg/day and 36.4 ± 8.8 mg/kg/day, respectively, in males, and 46.5 ± 9.4 mg/kg/day and 44.2 ± 9.6 mg/kg/day, respectively, in females.
Macroscopic observations at the end of the 26-week treatment period revealed white nodules/masses with a diameter of 1–3 mm on the forestomach mucosa in approximately half of the rasH2 mice in the 300 ppm group. Histopathologically, these nodules/masses were diagnosed as squamous cell hyperplasias, papillomas, and carcinomas (Figure 1). In our diagnostic criteria, squamous cell hyperplasia is characterized by focal or diffuse thickening of epithelial layer. Squamous cell papillomas consist of a stalk protruding into the lumen with multiple finger-like projections arising from the stalk, and squamous cell carcinomas show invasive proliferation into the submucosa. Squamous cell papillomas were frequently detected in male mice, whereas squamous cell hyperplasias were often detected in female mice (Table 2). The incidence of total proliferative lesions in the forestomach, including hyperplasias, papillomas, and carcinomas, in all rasH2 mice in the 300 ppm group was significantly higher than that in the 0 ppm group. In non-Tg mice, no significant differences in the incidences of forestomach lesions were observed between the 0 ppm and 300 ppm groups.
The results of histopathological examinations of the liver, spleen, lung, and skeletal muscles are shown in Table 3. The histopathological changes in the liver were more apparent in female mice than in male mice. Hepatocyte hypertrophy of periportal regions was observed only in female rasH2 mice and non-Tg mice in relation to IQ treatment and was accompanied by oval cell proliferation in many cases (Figure 2A–D, Table 3). Periportal hepatocyte hypertrophy was also seen in the liver of female rasH2 mice at week 13. Hepatocellular altered foci were detected in male and female mice; most of these foci were classified as the basophilic cell type. The incidence of altered foci in female rasH2 mice in the 300 ppm group was significantly increased when compared with that in the 0 ppm group. In the spleen and lung, which are the tumor target organs in short-term carcinogenicity studies of other carcinogens in rasH2 mice, no significant differences in the incidence of lesions relevant to IQ treatment were observed between rasH2 and non-Tg mice. Additionally, IQ-related histopathological changes were not detected in other organs. Skeletal myopathy was detected in almost all the rasH2 mice with or without IQ treatment, as reported by Tsuchiya et al. (2002).
The severity of eosinophilic changes in the epithelium of the nasal cavity varied between rasH2 mice and non-Tg mice. Based on the severity, the eosinophilic changes in the olfactory and respiratory epithelia were classified into slight (+), moderate (++), and severe (+++) (Figure 2E–H, Table 4). In the olfactory epithelium, the severity of eosinophilic changes significantly increased in all rasH2 mice when compared with that in non-Tg mice, although the incidence of this lesion in both mice was similar. In the respiratory epithelium, both the incidence and severity of eosinophilic changes in rasH2 mice were higher than those in non-Tg mice. The severity of these changes in both rasH2 and non-Tg mice did not correlate with IQ treatment.
It has been reported that in CDF1 mice, tumors in the liver, forestomach, and lung could be induced by feeding 300 ppm IQ for 96 weeks (Ohgaki et al., 1984). In the present study, IQ induced proliferative lesions in the forestomach of male and female rasH2 mice within 26 weeks of treatment; this suggests that rasH2 mice show carcinogenic susceptibility to IQ. Forestomach papillomas and carcinomas have been reported as one of the spontaneous tumors in rasH2 mice, although the incidences of these tumors were generally low (Mitsumori et al., 1998). In addition, the forestomach is extremely sensitive to various carcinogens, and numerous reports indicate that forestomach papillomas and/or squamous cell carcinomas were frequently induced by treatment with various carcinogens (Yamamoto et al., 1996; Usui et al., 2001). The E mu-pim-1 transgenic mice, which overexpresses the pim-1 oncogene in the lymphoid tissues, were reported to show high susceptibility to the induction of lymphoma by 2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine (PhIP), which induced lymphoma in the long-term carcinogenicity study in mice (Sorensen et al., 1996). However, these mice were not susceptible to the IQ treatment that the lymphoid tissue is not a carcinogenic target organ (Sorensen et al., 1996). Thus, the induction of forestomach tumors in this study may be attributed to the finding that the target organs of IQ were consistent with the organs that are sensitive to carcinogens in rasH2 mice. The incidence of the forestomach tumors induced by IQ in male CDF1 mice was higher than that in female mice (Ohgaki et al., 1984), and in this study, the carcinogenic susceptibility of male rasH2 mice was higher than that of female mice; this suggests that there is a sex difference in the carcinogenicity of IQ. IQ is metabolically activated and then forms bulky adducts in DNA, which is considered as a major factor of carcino-genesis by IQ (Schut and Snyderwine, 1999; Sugimira et al., 2004). DNA adducts produced by IQ are repaired mainly via the nucleotide excision repair mechanism, in contrast to DNA damage by alkylating agents, which are repaired mostly via the base excision repair (BER) and DNA strand break repair mechanisms (Sobol et al., 1999; Wu et al., 2003). Poly(ADP-ribose) polymerase-1 knockout mice, which show decreased BER efficiency, demonstrated no increase in the incidence of tumors induced by IQ; however, it showed an elevated susceptibility to carcinogenesis induced by alkylating agents (Ogawa et al., 2005). Since rasH2 mice showed increased susceptibility to IQ as well as alkylating agents such as N-bis(2-hydroxypropyl)nitrosamine (Okamura et al., 2004a), it Currently, mutation and overexpression of the transgene are considered to be the most probable mechanisms of enhanced carcinogenesis in rasH2 mice (Tamaoki, 2001). Point mutations in ras genes have been detected in tumors induced by IQ in rats and mice (Herzog et al., 1993; Nagao et al., 1997). Therefore, mutation of the transgene might occur in the forestomach tumors in rasH2 mice after treatment with IQ. On the other hand, overexpression of the transgene was detected in the forestomach and lung tumors in rasH2 mice, irrespective of the mutation frequency of the transgene (Tamaoki, 2001; Toyosawa et al., 2003; Okamura et al., 2004b). Accordingly, the overexpression of the transgene might be involved in the tumorigenesis by IQ. Histopathological changes such as periportal hepatocellular hypertrophy and oval cell proliferation in the liver were more apparent in female mice than in male mice, and the hepatocellular altered foci were increased in female rasH2 mice fed with IQ. In CDF1 mice, the sensitivity of females to the induction of liver tumor was approximately twice that of males (Ohgaki et al., 1984). Because it is well known that oval cell proliferation and basophilic foci are induced by hepato-carcinogens (Goldfarb et al., 1983; He et al., 1994), female rasH2 mice are considered to be more sensitive to hepatocar-cinogenesis induced by IQ than male rasH2 mice, as in the case of CDF1 mice. IQ is metabolized by cytochrome P450 (CYP) 1A2 mainly in the liver and induces its activating enzyme (Nerurkar et al., 1993). Thus, there is a possibility that periportal hepatocyte hypertrophy is probably caused by the induction of enzyme. However, since the localization pattern of CYP 1A2 induction is not always specific to the periportal region (Oinonen and Lindros, 1998), further studies are required to clarify the causes of hepatocyte hypertrophy. In the present study, we found that the severity of eosinophilic changes in the olfactory and respiratory epithelia varied between rasH2 mice and non-Tg mice; the severity of eosinophilic changes in the olfactory epithelium significantly increased in rasH2 mice as compared to that in non-Tg mice, and both the incidence and severity of eosinophilic changes in the respiratory epithelium in rasH2 mice were higher than those in non-Tg mice. It is known that these eosinophilic changes occur spontaneously in aged rats and mice, although the etiology of these changes is uncertain (Nagano et al., 1997). In rasH2 mice, skeletal myopathy, which is characterized by variation in muscle fiber size, centrally placed nuclei, regenerating fibers, and interstitial fibrosis, has been reported to be a spontaneous histopathological lesion with no difference with respect to gender (Tsuchiya et al., 2002). The myopathic changes were observed with aging and were detected in almost 100% of 34-week-old rasH2 mice (Tsuchiya et al., 2002; Tsuchiya et al., 2005). Although the integration of the c-Ha-ras gene is thought to be crucial, the underlying mechanism of its pathogenesis remains to be elucidated. Similarly, the severe eosinophilic changes in the nasal epithelial cells are considered to be one of the spontaneous histopathological lesions in rasH2 mice, and further studies are necessary to clarify the rationale behind a high severity of such lesions in rasH2 mice as compared to the non-Tg mice.
This work was supported in part by Grants-in-Aid for Cancer Research from the Ministry of Health, Labour and Welfare of Japan.
Adamson, RH, Thorgeirsson, UP, Snyderwine, EG, Thorgeirsson, SS, Reeves, J, Dalgard, DW, Takayama, S, & Sugimura, T. (1990). Carcinogenicity of 2-amino-3-methylimidazo[4,5-f]quinoline in nonhuman primates: induction of tumors in three macaques. Jpn J Cancer Res, 81, 10-4[CrossRef][Web of Science] Dashwood, RH. (2003). Use of transgenic and mutant animals models in the study of heterocyclic amine-induced mutagenicity and carcinogenesis. J Biochem Mol Biol, 36, 35-42[Web of Science][Medline] [Order article via Infotrieve] Goldfarb, S, Pugh, TD, Koen, H, & He, YZ. (1983). Preneoplastic and neoplastic progression during hepatocarcinogenesis in mice injected with diethylnitrosamine in infancy. Environ Health Perspect, 50, 149-61[Web of Science][Medline] [Order article via Infotrieve] He, XY, Smith, GJ, Enno, A, & Nicholson, RC. (1994). Short-term diethylnitrosamine-induced oval cell responses in three strains of mice. Pathology, 26, 154-60[CrossRef][Web of Science][Medline] [Order article via Infotrieve] Herzog, CR, Schut, HA, Maronpot, RR, & You, M. (1993). ras mutations in 2-amino-3-methylimidazo-[4,5-f]quinoline-induced tumors in the CDF1 mouse. Mol Carcinog, 8, 202-7[Web of Science][Medline] [Order article via Infotrieve] International Agency for Research on Cancer. (1993). IQ. IARC Monographs on the Evaluation of Carcinogenic Risks to Humans, Some Naturally Occurring Substances: Food Items and Constituents, Heterocyclic Aromatic Amines and Mycotoxins (pp.56-165). Lyon, France: IARC Mitsumori, K, Koizumi, H, Nomura, T, & Yamamoto, S. (1998). Pathological features of spontaneous and induced tumors in transgenic mice carrying a human prototype c-Ha-ras gene used for six-month carcinogenicity studies. Toxicol Pathol, 26, 520-31 Morton, D, Alden, CL, Roth, AJ, & Usui, T. (2002). The Tg rasH2 mouse in cancer hazard identification. Toxicol Pathol, 30, 139-46 Nagano, K, Katagiri, T, Aiso, S, Senoh, H, Sakura, Y, & Takeuchi, T. (1997). Spontaneous lesions of nasal cavity in aging F344 rats and BDF1 mice. Exp Toxicol Pathol, 49, 97-104[Web of Science][Medline] [Order article via Infotrieve] Nagao, M, Ushijima, T, Toyota, M, Inoue, R, & Sugimura, T. (1997). Genetic changes induced by heterocyclic amines. Mutat Res, 376, 161-7[Web of Science][Medline] [Order article via Infotrieve] Nerurkar, PV, Anderson, LM, Snyderwine, EG, Park, SS, Thorgeirs-son, SS, & Rice, JM. (1993). Specific induction of hepatic cy-tochrome P4501a-2 in C57BL/6 and DBA/2 mice treated with 2-amino-3-methylimidazo[4,5-f]quinoline (IQ). J Biochem Toxicol, 8, 175-86[CrossRef][Web of Science][Medline] [Order article via Infotrieve] Ogawa, K, Masutani, M, Kato, K, Tang, M, Kamada, N, Suzuki, H, Nakagama, H, Sugimura, T, & Shirai, T. (2005). Parp-1 defi-ciency does not enhance liver carcinogenesis induced by 2-amino-3-methylimidazo[4,5-f]quinoline in mice. Cancer Lett. in press. in press. in press. Ohgaki, H, Kusama, K, Matsukura, N, Morino, K, Hasegawa, H, Sato, S, Takayama, S, & Sugimura, T. (1984). Carcinogenicity in mice of a mutagenic compound, 2-amino-3-methylimidazo[4,5-f]quinoline, from broiled sardine, cooked beef and beef extract. Carcinogenesis, 5, 921-4 Oinonen, T, & Lindros, KO. (1998). Zonation of hepatic cytochrome P-450 expression and regulation. Biochem J, 329 ( Pt 1), 17-35[Web of Science][Medline] [Order article via Infotrieve] Okamura, M, Moto, M, Kashida, Y, Machida, N, & Mitsumori, K. (2004a). Carcinogenic susceptibility to N-bis(2-hydroxypropyl)nitrosamine (DHPN) in rasH2 mice. Toxicol Pathol, 32, 474-81[CrossRef][Web of Science][Medline] [Order article via Infotrieve] Okamura, M, Sumida, K, Muto, T, Kashida, Y, Machida, N, Watanabe, T, & Mitsumori, K. (2004b). Analysis of gene expression profiles of forestomach tumors in rasH2 mice initiated with N-ethyl-N-nitrosourea. Arch Toxicol, 78, 688-96[CrossRef][Web of Science][Medline] [Order article via Infotrieve] Robinson, DE, & MacDonald, JS. (2001). Background and framework for ILSI’s collaborative evaluation program on alternative models for carcinogenicity assessment. International Life Sciences Institute. Toxicol Pathol, 29(Suppl), 13-9 Saito, A, Kimura, M, Takahashi, R, Yokoyama, M, Nomura, T, Izawa, M, Sekiya, T, Nishimura, S, & Katsuki, M. (1990). Most tumors in transgenic mice with human c-Ha-ras gene contained somatically activated transgene. Oncogene, 5, 1195-200[Web of Science][Medline] [Order article via Infotrieve] Schut, HA, & Snyderwine, EG. (1999). DNA adducts of heterocyclic amine food mutagens: implications for mutagenesis and carcinogenesis. Carcino-genesis, 20, 353-68 Sobol, RW, Watson, DE, Nakamura, J, Yakes, FM, Hou, E, Horton, JK, Ladapo, J, Van Houten, B, Swenberg, JA, Tindall, KR, Samson, LD, & Wilson, SH. (1999). Mutations associated with base excision repair deficiency and methylation-induced genotoxic stress. Proc Natl Acad Sci USA, 99, 6860-65[CrossRef] Sorensen, IK, Mortensen, A, Kristiansen, E, van Kreijl, C, Adamson, RH, & Thorgeirsson, SS. (1996). Short-term carcinogenicity testing of 2-amino-1-methyl-6- phenylimidazo[4,5-b]pyridine (PhIP) and 2-amino-3-methylimidazo[4,5-f]quinoline (IQ) in E(mu)-pim-1 transgenic mice. Carcinogenesis, 17, 2221-7 Suemizu, H, Muguruma, K, Maruyama, C, Tomisama, M, Kimura, M, Hioki, K, Shimozawa, N, Ohnishi, Y, Tamaoki, N, & Nomura, T. (2002). Transgene stability and features of rasH2 mice as an animal model for short-term carcinogenicity testing. Mol Carcinog, 34, 1-9[CrossRef][Web of Science][Medline] [Order article via Infotrieve] Sugimura, T, Wakabayashi, K, Nakagama, H, & Nagao, M. (2004). Heterocyclic amines: Mutagens/carcinogens produced during cooking of meat and fish. Cancer Sci, 95, 290-9[CrossRef][Medline] [Order article via Infotrieve] Takayama, S, Nakatsuru, Y, Masuda, M, Ohgaki, H, Sato, S, & Sugimura, T. (1984). Demonstration of carcinogenicity in F344 rats of 2-amino-3-methyl-imidazo[4,5-f]quinoline from broiled sardine, fried beef and beef extract. Gann, 75, 467-70[Web of Science][Medline] [Order article via Infotrieve] Tamaoki, N. (2001). The rasH2 transgenic mouse: nature of the model and mechanistic studies on tumorigenesis. Toxicol Pathol, 29(Suppl), 81-9 Toyosawa, K, Tanaka, K, Imai, T, Yasuhara, K, Koujitani, T, Hirose, M, & Mitsumori, K. (2003). Mutation and overexpression of the transgene in ethylnitrosourea-induced tumors in mice carrying a human prototype c-Ha-ras gene. Toxicol Pathol, 31, 491-5 Tsuchiya, T, Kobayashi, K, Sakairi, T, Goto, K, Okada, M, Sano, F, Sugimoto, J, Morohashi, T, Usui, T, & Mutai, M. (2002). Skeletal myopathy in transgenic mice carrying human prototype c-Ha-ras gene. Toxicol Pathol, 30, 501-6 Tsuchiya, T, Okada, M, Sakairi, T, Sano, F, Sugimoto, J, & Takagi, S. (2005). Histopathological characterization of the skeletal myopathy in rasH2 mice carrying human prototype c-Ha-ras gene. J Vet Med Sci, 67, 481-9[CrossRef][Web of Science][Medline] [Order article via Infotrieve] Usui, T, Mutai, M, Hisada, S, Takaoka, M, Soper, KA, McCullough, B, & Alden, C. (2001). CB6F1-rasH2 mouse: overview of available data. Toxicol Pathol, 29(Suppl), 90-108 Wu, RW, Panteleakos, FN, & Felton, JS. (2003). Development and characterization of CHO repair-proficient cell lines for comparative mutagenicity and metabolism of heterocyclic amines from cooked food. Environ Mol Mutagen, 41, 7-13[CrossRef][Web of Science][Medline] [Order article via Infotrieve] Yamamoto, S, Mitsumori, K, Kodama, Y, Matsunuma, N, Manabe, S, Okamiya, H, Suzuki, H, Fukuda, T, Sakamaki, Y, Sunaga, M, Nomura, G, Hioki, K, Wakana, S, Nomura, T, & Hayashi, Y. (1996). Rapid induction of more malignant tumors by various genotoxic carcinogens in transgenic mice harboring a human prototype c-Ha-ras gene than in control non-transgenic mice. Carcinogenesis, 17, 2455-61
Toxicologic Pathology, Vol. 34, No. 2,
199-205 (2006)
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
 |
|
|
 |
|
Sign In to gain access to subscriptions and/or personal tools.
Top
Abstract
Introduction
